MedPath
FDA Approval

LUMIGAN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 31, 2010
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Bimatoprost(0.1 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LUMIGAN

Product Details

NDC Product Code
54868-6304
Application Number
NDA022184
Marketing Category
NDA (C73594)
Route of Administration
OPHTHALMIC
Effective Date
September 30, 2011
Code: QXS94885MZClass: ACTIBQuantity: 0.1 mg in 1 mL
sodium chlorideInactive
Code: 451W47IQ8XClass: IACT
sodium phosphate, dibasicInactive
Code: GR686LBA74Class: IACT
benzalkonium chlorideInactive
Code: F5UM2KM3W7Class: IACT
waterInactive
Code: 059QF0KO0RClass: IACT
citric acid monohydrateInactive
Code: 2968PHW8QPClass: IACT
Sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
hydrochloric acidInactive
Code: QTT17582CBClass: IACT

LUMIGAN

Product Details

NDC Product Code
54868-4575
Application Number
NDA021275
Marketing Category
NDA (C73594)
Route of Administration
OPHTHALMIC
Effective Date
September 30, 2011
sodium chlorideInactive
Code: 451W47IQ8XClass: IACT
benzalkonium chlorideInactive
Code: F5UM2KM3W7Class: IACT
Code: QXS94885MZClass: ACTIBQuantity: 0.3 mg in 1 mL
sodium phosphate, dibasicInactive
Code: GR686LBA74Class: IACT
hydrochloric acidInactive
Code: QTT17582CBClass: IACT
citric acid monohydrateInactive
Code: 2968PHW8QPClass: IACT
Sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
waterInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath